Surgery for Bentall endocarditis: short- and midterm outcomes from a multicentre registry

• Published in: European journal of cardio-thoracic surgery Vol. 58; no. 4; pp. 839 - 846
• Main Authors: Sponga, Sandro, Di Mauro, Michele, Malvindi, Pietro G, Paparella, Domenico, Murana, Giacomo, Pacini, Davide, Weltert, Luca, De Paulis, Ruggero, Cappabianca, Giangiuseppe, Beghi, Cesare, De Vincentiis, Carlo, Parolari, Alessandro, Messina, Antonio, Troise, Giovanni, Salsano, Antonio, Santini, Francesco, Pierri, Michele D, Di Eusanio, Marco, Maselli, Daniele, Actis Dato, Guglielmo, Centofanti, Paolo, Mancuso, Samuel, Rinaldi, Mauro, Cagnoni, Giuseppe, Antona, Carlo, Picichè, Marco, Salvador, Loris, Cugola, Diego, Galletti, Lorenzo, Pozzoli, Alberto, De Bonis, Michele, Lorusso, Roberto, Bortolotti, Uberto, Livi, Ugolino
• Format: Journal Article
• Language: English
• Published: Germany Oxford University Press 01.10.2020
• Subjects: Aortic root; Bentall procedure; Aortic surgery; Aortic valve; Endocarditis
• ISSN: 1010-7940; 1873-734X
• DOI: 10.1093/ejcts/ezaa136

Abstract OBJECTIVES Endocarditis after the Bentall procedure is a severe disease often complicated by a pseudoaneurysm or mediastinitis. Reoperation is challenging but conservative therapy is not effective. The aim of this study was to assess short- and midterm outcomes of patients reoperated on for Bentall-related endocarditis. METHODS Seventy-three patients with Bentall procedure-related endocarditis were recorded in the Italian registry. The mean age was 57 ± 14 years and 92% were men; preoperative comorbidities included hypertension (45%), diabetes (12%) and renal failure (11%). The logistic EuroSCORE was 25%; the EuroSCORE II was 8%. RESULTS Preoperatively, 12% of the patients were in septic shock; left ventricular-aortic discontinuity was present in 63% and mitral valve involvement occurred in 12%. The most common pathogens were Staphylococcus aureus (22%) and Streptococci (14%). Reoperations after a median interval of 30 months (1–221 months) included a repeat Bentall with a bioconduit (41%), a composite mechanical (33%) or biological valved conduit (19%) and a homograft (6%). In 1 patient, a heart transplant was required (1%); in 12%, a mitral valve procedure was needed. The hospital mortality rate was 15%. The postoperative course was complicated by renal failure (19%), major bleeding (14%), pulmonary failure (14%), sepsis (11%) and multiorgan failure (8%). At multivariate analysis, urgent surgery was a risk factor for early death [hazard ratio 20.5 (1.9–219)]. Survival at 5 and 8 years was 75 ± 6% and 71 ± 7%, with 3 cases of endocarditis relapse. CONCLUSIONS Surgery is effective in treating endocarditis following the Bentall procedure although it is associated with high perioperative mortality and morbidity rates. Endocarditis relapse seems to be uncommon.